Bio-Templated Zinc Oxide Nanotherapeutics from Flemingia macrophylla kuntze Ex Merr: In Vivo Anti-Diabetic and Anti-Inflammatory Efficacy in Drosophila melanogaster
- 1Department of Developmental Biology and Genetics (DBG), Indian Institute of Science (IISc)
Abstract
Nanotechnology has a major impact on the creation of novel and effective therapies for the treatment of several diseases, including diabetes and cancer. The current work is a report on the use of the aqueous extract from the leaves of the Flemingia macrophylla plant as a capping and reducing agent in the green synthesis of zinc oxide nanoparticles (ZnO-NPs).The synthesized ZnO-NPs were subjected to characterization through X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), transmission electron microscopy (TEM) scanning electron microscopy (SEM), and ultraviolet-visible spectroscopy (UV-Vis). Dose-dependent in vivo effects were investigated using Drosophila melanogaster subjected to a high-sugar diet (HSD) to induce a diabetic-like model. In vitro anti-oxidant, anti-diabetic, anti-inflammatory assay, survival, locomotor function, neuroanatomical integrity, ovary and testis morphology, egg-laying capacity, and male fertility were evaluated. The most prominent UV-visible peak was detected at around 370 nm. Structural and morphological analysis via XRD and electron microscopy confirmed the hexagonal phase of the ZnO-NPs, indicating an average calcined particle size of around 47 nm at 500 degree C. The manuscript reports significant anti-diabetic and anti-inflammatory effects in vitro and in the in vivo Drosophila model, together with antioxidant activity. The in vivo results indicate that green-synthesized ZnO-NPs mitigate adverse phenotypes triggered by a high-sugar diet and also potential as an anti-diabetic intervention and warrant further mechanistic and preclinical investigation. Keywords: Flemingia macrophylla; Green ZnO-NPs; Drosophila melanogaster; high-sugar diet; nanobiotechnology
Related
- Protective effects of Gentiana macrophylla Pall. against blue light-induced retinal injury associated with of antioxidant defense, mitochondrial dysfunction, apoptosis, and inflammatory responses
- Time-averaged simulated microgravity ameliorates tau-induced deficit in Drosophila melanogaster
- Evaluation of the genotoxic potential of two rice herbicides, cyhalofop-butyl and quinclorac, in Drosophila melanogaster
- Co-administration of simvastatin mitigates clozapine-induced lifespan extension and mitochondrial functional recovery in Drosophila melanogaster.
- Antioxidant response and neurotransmitter modulation driven by oleuropein/alpha-lipoic acid attenuates lead-induced reproductive toxicity and neurotoxicity in Drosophila melanogaster
BibTeX
@misc{khongsai2026biotemplated,
title = {{Bio-Templated Zinc Oxide Nanotherapeutics from Flemingia macrophylla kuntze Ex Merr: In Vivo Anti-Diabetic and Anti-Inflammatory Efficacy in Drosophila melanogaster}},
author = {L. Khongsai and R. Sarkar and A. R. Singh and A. S. Singh and B. K. Bindhani and U. Nongthomba and C. B. Singh},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.20.760481},
url = {https://www.biorxiv.org/content/10.64898/2026.10.20.760481v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Bio-Templated Zinc Oxide Nanotherapeutics from Flemingia macrophylla kuntze Ex Merr: In Vivo Anti-Diabetic and Anti-Inflammatory Efficacy in Drosophila melanogaster
AU - L. Khongsai
AU - R. Sarkar
AU - A. R. Singh
AU - A. S. Singh
AU - B. K. Bindhani
AU - U. Nongthomba
AU - C. B. Singh
PY - 2026
DA - 2026/10/20
PB - bioRxiv
DO - 10.64898/2026.10.20.760481
UR - https://www.biorxiv.org/content/10.64898/2026.10.20.760481v1
AB - Nanotechnology has a major impact on the creation of novel and effective therapies for the treatment of several diseases, including diabetes and cancer. The current work is a report on the use of the aqueous extract from the leaves of the Flemingia macrophylla plant as a capping and reducing agent in the green synthesis of zinc oxide nanoparticles (ZnO-NPs).The synthesized ZnO-NPs were subjected to characterization through X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), transmission electron microscopy (TEM) scanning electron microscopy (SEM), and ultraviolet-visible spectroscopy (UV-Vis). Dose-dependent in vivo effects were investigated using Drosophila melanogaster subjected to a high-sugar diet (HSD) to induce a diabetic-like model. In vitro anti-oxidant, anti-diabetic, anti-inflammatory assay, survival, locomotor function, neuroanatomical integrity, ovary and testis morphology, egg-laying capacity, and male fertility were evaluated. The most prominent UV-visible peak was detected at around 370 nm. Structural and morphological analysis via XRD and electron microscopy confirmed the hexagonal phase of the ZnO-NPs, indicating an average calcined particle size of around 47 nm at 500 degree C. The manuscript reports significant anti-diabetic and anti-inflammatory effects in vitro and in the in vivo Drosophila model, together with antioxidant activity. The in vivo results indicate that green-synthesized ZnO-NPs mitigate adverse phenotypes triggered by a high-sugar diet and also potential as an anti-diabetic intervention and warrant further mechanistic and preclinical investigation. Keywords: Flemingia macrophylla; Green ZnO-NPs; Drosophila melanogaster; high-sugar diet; nanobiotechnology
ER -